This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Ipca Laboratories seeks Indian merger clearance for controlling stake in Unichem

By Freny Patel ( May 18, 2023, 23:13 GMT | Insight) -- Ipca Laboratories has sought merger approval for its proposed acquisition of a controlling stake of up to 59.38 percent in Unichem Laboratories — a deal that would grant Ipca management control over its Mumbai-based pharmaceutical-ingredients peer. Despite horizontal and vertical overlaps, the companies told the Competition Commission of India that the proposed combination wouldn’t raise any competition concerns nor cause any appreciable adverse effect on competition in the domestic market. Ipca Laboratories has sought merger approval for its proposed acquisition of a controlling stake of up to 59.38 percent in Unichem Laboratories — a deal that would grant Ipca management control over its Mumbai-based pharmaceutical-ingredients peer....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login